Advertisement

Topics

Companies Related to "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization" [Most Relevant Company Matches] - Page: 4 RSS

13:52 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization" found in our extensive corporate database of over 50,000 company records.

Showing "NASPI Acetylcysteine Ascorbic Acid Prevention Contrast Induced Nephropathy" Companies 76–100 of 1,000+

Probably Relevant

NovaBay Pharmaceuticals, Inc.:

NovaBay Pharmaceuticals is a biopharmaceutical company focusing on the commercialization of prescription Avenova® Lid and Lash Cleanser for the eye care market. Avenova is formulated with Neutrox™, which is cleared by the U.S. Food and Drug Administration (FDA) as a 510(k) medical device. Neutrox is NovaBay’s pure hypochlorous acid. Laboratory...


TapImmune, Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patients’ killer T...

Human Performance Institute Division of Wellness & Prevention, Inc.

Wellness & Prevention, Inc., a Johnson & Johnson company, helps organizations renew the health, energy, and performance of their employees and members, and offers an integrated portfolio of solutions to cover a broad spectrum of population health – from wellness and prevention, to behavioral health, to chronic disease support. These solutions include ...


DNA Electronics

DNA Electronics is a developer of semiconductor solutions for real-time nucleic acid detection which enables faster, simpler and more cost-effective DNA analysis platforms. The company’s IP portfolio includes techniques for monitoring nucleotide insertions using ion-sensitive transistors, enabling label-free electronic DNA sequencing and diagnostics p...

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

Lantheus Medical Imaging, Inc. and NTP Radioisotopes

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. The Company’s proven success in the field of diagnostic imaging provides a strong platform from which ...

Botvin LifeSkills Training

Botvin LifeSkills Training is a highly effective evidence-based substance abuse and violence prevention program with more than 25 years of peer-reviewed research behind it. The program was developed by Dr. Gilbert J. Botvin, professor of Public Health and Psychiatry at Cornell University's Weill Medical College and director of Cornell's Institute for Prevention Research. LifeSkills Training is inc...

MedaSorb Technologies

MedaSorb Technologies (“MedaSorb” or the “Company) has developed a new platform technology that efficiently removes toxic compounds from the bloodstream. Current state-of-the-art blood purification techniques are not designed for this purpose and are inefficient at removing these toxins. The Company’s products, which incorporate a proprietary adsorbent polymer technology, are known medical...

Boston Probes

Boston Probes, Inc., headquartered in Bedford, Massachusetts, is a leader in the development of peptide nucleic acid (PNA) probe technology for use in human in vitro diagnostics, agriculture, veterinary, environmental, and industrial testing.The company was founded in 1996 by three scientists who were involved in the early development of PNA, a synthetic nucleic acid mimic. The founders were so in...

Cortex Biochem Incorporated

Cortex Biochem, Inc. is a biotechnology company, located in San Leandro, California, with a long-standing specialty in magnetic separation technology.The introduction of MagaZorb™ a revolutionary easy to use magnetic separation technology for nucleic acid isolation that is ideal for manual, semi-automated, and fully-automated nucleic acid isolation platforms is a result of combining three of our...

American Liver Foundation

The American Liver Foundation is the nation’s largest non-profit organization focused solely on promoting liver health and disease prevention. The mission of the American Liver Foundation is to facilitate, advocate and promote education, support and research for the prevention, treatment and cure of liver disease.

Aradigm Corporation and Grifols S.A.

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Aradigm has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and prevention of ...

Celanese Corporation

We are an integrated global producer of value-added industrial chemicals and have the first or second market positions worldwide in products comprising the majority of our sales. We are the world’s largest producer of acetyl products, including acetic acid and vinyl acetate monomer ("VAM"), polyacetal products ("POM"), as well as a leading global producer of high-performance engineered polymers ...

Cullgen Inc.

Cullgen is a drug discovery company leveraging ubiquitin-mediated, small molecule-induced protein degradation technology. The company's research programs focus on novel treatment for cancer, inflammatory, and autoimmune diseases. For more information, visit www.cullgen.com.

Endocyte

Endocyte is developing a new generation of receptor-targeted therapeutics or "smart drugs" for the treatment of cancer and autoimmune diseases. Current non-targeted drugs are usually toxic to normal healthy cells causing serious side effects. These side effects can be life-threatening which leads to suboptimal dosing. Receptor-targeted therapeutics can be more effective because they can be targete...

XCR Diagnostics, Inc.

XCR Diagnostics, Inc. is an early-stage nucleic acid system company advancing near patient portable molecular diagnostics instrumentation, sample delivery systems, amplification, detection and analysis to the diagnostic markets, domestically and internationally. The company is positioned to provide the first sub-10-minute to a negative test result t...

A/F Protein Inc

To develop the use of antifreeze proteins for the control of cold-induced damage in medical, food, and cosmetic products. A/F Protein Inc. is the world's only commercial producer of antifreeze proteins purified from natural sources for sale to the research and development community.

TrovaGene, Inc.

With its headquarters and product development in San Diego, California, TrovaGene has focused on development of tests using its patented transrenal nucleic acid technology. Transrenal DNA (Tr-DNA) and RNA (Tr-RNA) are short nucleic acid fragments from normal cell death that cross the kidney barrier and can be detected in urine. Safe and simple urine collec...

Xdynia LLC

Xdynia LLC is a Charlottesville, Virginia based preclinical pharmaceutical company developing drugs that inhibit Cav3.2 for the treatment of neuropathic pain, chemotherapy-induced neuropathy, and tremor. Xdynia's library of Cav3.2 inhibitors were developed by world experts in T-type calcium channels.

Wuxi Jiaxue International Trading Co., Ltd.

As one of main exporter of Chiral Compounds(Tartaric Acid Ramification & others) located in China

ChanTest Inc.

To provideNon-Clinical drug safety testing and discovery services that accelerate drug development by:Leveraging our extensive experience in evaluating drug-induced effects on ion channels, purkinje fibers, and iolated hearts; Providing accurate, repeatable results; Consistently responding with a high sense of urgency

Synvista Therapeutics, Inc.

Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company believes it has identified several product candidates that represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione pero...

Rockwell Medical Technologies

Rockwell started in January 1995, with four employees, when it began manufacturing and distributing dialysis kits and other ancillary dialysis products. In January of 1996, the Company moved into a new 35,000 square foot manufacturing plant and began production and distribution of acid concentrate and bicarbonate along with ancillary dialysis products. The Company successfully completed an initial...

ILEX Oncology Incorporated

ILEX Oncology, Inc. is a drug development company focused exclusively on accelerated development of drugs for thetreatment and prevention of cancer. The Company uses its expertise in the identification, development, manufacturing and regulatory approval process of oncology drugs to (i) develop cancer treatment products, (ii) develop products for the prevention of cancer and (iii) provide contract ...

PreCare, Inc.

PreCare is the leading national provider of onsite Injury Prevention, Wellness, Physical Therapy Treatment and Return to Work Job Coaching, and Consulting Services. Clients include Fortune 2000 Self-insured Employers in the Workers’ Compensation and Integrated Disability markets. PreCare’s innovative onsite deployment combines preve...


More From BioPortfolio on "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks